Company: NDRA
Filing Date: 2025-07-25
Form Type: S-1/A
Source: 0001654954-25-008477
Chunk: 18

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-07-25
Form: S-1/A
Chunk 18
---
 utilize all of its cash allocated to its treasury strategy and used to purchase cryptocurrency to purchase bitcoin. To the extent that any of our assets allocated to our cryptocurrency treasury strategy is not held in bitcoin or other cryptocurrencies, it will be held in cash deposits or cash management instruments, such as U.S. government securities or money market mutual funds.    See the section titled “Use of Proceeds.” |
| Nasdaq Capital Market symbol                                |     | NDRA. We do not intend to apply for listing of the Pre-Funded Warrants on any securities exchange or other nationally recognized trading system. Without an active trading market, the liquidity of the Pre-Funded Warrants will be limited.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Risk factors                                                |     | See the section titled “Risk Factors” and other information included and incorporated by reference into this prospectus for a discussion of factors you should consider before investing in our securities.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |

| 13 |

| The number of shares of our common stock to be outstanding after this offer is based on 752,755 shares of common stock outstanding as of July 24, 2025 and excludes the following: |   |                                                                                                                                                                                                                            |
|                                                                                                                                                                                    | · | 180,707 shares of common stock issuable upon the exercise of outstanding warrants at a weighted-average exercise price of $85.38 per share;                                                                                |
|                                                                                                                                                                                    | · | 1 share of common stock issuable upon the conversion of outstanding shares of Series A Convertible Preferred Stock;                                                                                                        |
|                                                                                                                                                                                    | · | 266 shares of common stock issuable upon the exercise of outstanding stock options issued pursuant to our 2016 Omnibus Incentive Plan (the “Incentive Plan”) at a weighted average exercise price of $26,594.61 per share; |
|                                                                                                                                                                                    | · | 179,474 shares of common stock issuable upon the vesting of Restricted Stock Units issued pursuant to the Incentive Plan; and                                                                                              |
|                                                                                                                                                                                    | · | 309 shares of common stock reserved for future issuance under the Incentive Plan.                                                                                                                                          |

| 14 |

<div align='center'>RISK FACTORS</div>

Investing in our securities involves risks. Before you make a decision to buy our securities, in addition to the risks and uncertainties discussed above under “Cautionary Note Regarding Forward-Looking Statements,” you should read and consider carefully the following